Regulatory (FoxP3(+)) T cells and TGF-β predict the response to anti-PD-1 immunotherapy in patients with non-small cell lung cancer

類似資料

• MDSC subtypes and CD39 expression on CD8(+) T cells predict the efficacy of anti‐PD‐1 immunotherapy in patients with advanced NSCLC
  著者:: Koh, Jiae, 等
  出版事項: (2020)
• Immunological Characteristics of Hyperprogressive Disease in Patients with Non-small Cell Lung Cancer Treated with Anti-PD-1/PD-L1 Abs
  著者:: Kim, Kyung Hwan, 等
  出版事項: (2020)
• Immune-related adverse events are clustered into distinct subtypes by T-cell profiling before and early after anti-PD-1 treatment
  著者:: Kim, Kyung Hwan, 等
  出版事項: (2020)
• Mutational status of TP53 defines the efficacy of Wee1 inhibitor AZD1775 in KRAS-mutant non-small cell lung cancer
  著者:: Ku, Bo Mi, 等
  出版事項: (2017)
• TGFβ-induced FoxP3(+) Regulatory T Cells Rescue Scurfy Mice
  著者:: Huter, Eva N., 等
  出版事項: (2008)